Evidence map›Paper›PMID 42082699›Full record

ArticleBone marrow transplantation2026

Impact of donor and recipient EBV serostatus on transplant outcomes in patients with acute leukemia after haploidentical hematopoietic cell transplantation with post-transplant cyclophosphamide: Infectious Diseases Working Party EBMT retrospective study.

Jan Styczynski, Gloria Tridello, Inge Verheggen, Nina Knelange, Lotus Wendel, Per Ljungman, Jose Luis Piñana, Malgorzata Mikulska, Lidia Gil, Simone Cesaro and 15 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors.

Jan StyczynskiDepartment of Pediatric Hematology, Oncology, Immunology and Transplantology; Jurasz University Hospital 1, Collegium Medicum, Nicolaus Copernicus University, Bydgoszcz, Poland. jstyczynski@cm.umk.pl.ORCID http://orcid.org/0000-0002-3158-119X
Gloria TridelloEBMT Leiden Study Unit, Leiden, The Netherlands.
Inge VerheggenEBMT Leiden Study Unit, Leiden, The Netherlands.ORCID http://orcid.org/0000-0001-7749-5994
Nina KnelangeEBMT Leiden Study Unit, Leiden, The Netherlands.
Lotus WendelEBMT Leiden Study Unit, Leiden, The Netherlands.
Per LjungmanDepartment of Cellular Therapy and Allogeneic Stem Cell Transplantation, and Department of Infectious Diseases, Karolinska Comprehensive Cancer Center, Karolinska University Hospital, Department of Medicine Huddinge, Karolinska Institutet Stockholm, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-8281-3245
Jose Luis PiñanaDepartment of Hematology. Hospital Clínico Universitario of Valencia, INCLIVA, Biomedical Research Institute, Valencia, Spain.ORCID http://orcid.org/0000-0001-8533-2562
Malgorzata MikulskaDivision of Infectious Diseases, Department of Health Sciences (DISSAL), University of Genova, IRCCS Ospedale Policlinico San Martino, Genova, Italy.ORCID http://orcid.org/0000-0002-5535-4602
Lidia GilDepartment of Hematology, Poznan University of Medical Sciences, Poznan, Poland.
Simone CesaroPediatric Hematology Oncology, Department of Mother and Child, Azienda Ospedaliera Universitaria Integrata Verona, Verona, Italy.ORCID http://orcid.org/0000-0002-8698-9547
Fabio CiceriUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.ORCID http://orcid.org/0000-0003-0873-0123
Raffaella GrecoUnit of Hematology and Bone Marrow Transplantation, IRCCS San Raffaele Hospital, Vita-Salute San Raffaele University, Milan, Italy.ORCID http://orcid.org/0000-0002-6117-5328
Depei WuFirst Affiliated Hospital of Soochow University, Suzhou, China.ORCID http://orcid.org/0000-0002-6312-3863
Didier BlaiseTransplant and cellular immunotherapy program, Department of Hematology, Institut Paoli Calmettes, Sport Cancer Management lab, Aix Marseille University, Marseille, France.ORCID http://orcid.org/0000-0002-5684-9447
Raffaella CerrettiFondazione Policlinico Tor Vergata, Rome, Italy.ORCID http://orcid.org/0000-0003-3638-0650
Patrice ChevallierCHU Nantes, Nantes, France.ORCID http://orcid.org/0000-0003-3142-5581
Edouard ForcadeCHU Bordeaux, Hopital Haut-Leveque, Pessac, France.ORCID http://orcid.org/0000-0002-8873-2868
Flore Sicre de FontbruneSaint-Louis Hospital, BMT Unit, Paris, France.ORCID http://orcid.org/0000-0003-2000-1556
Mohamad MohtySorbonne University, Hopital Saint Antoine, INSERM UMRs 938, Paris, France.ORCID http://orcid.org/0000-0002-7264-808X
Sophie Ducastelle LepretreHopital Lyon Sud, Hospices Civils de Lyon, Lyon, France.
Claude Eric BulaboisCHU Grenoble Alpes-Universite Grenoble Alpes, Grenoble, France.
Stephanie Nguyen QuocUniversite Paris IV, Hopital la Pitie-Salpetriere, Paris, France.
Ibrahim Yakoub-AghaCHU de Lille, University of Lille, INSERM U1286, Infinite, Lille, France.ORCID http://orcid.org/0000-0003-4524-8782
Rafael de la CamaraHospital de la Princesa, Madrid, Spain.ORCID http://orcid.org/0000-0002-8189-5779
Dina AverbuchFaculty of Medicine, Hadassah Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.ORCID http://orcid.org/0000-0001-9614-7274

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42082699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.